Profile
Dr. Cheryl Cui is a Partner at Nest.Bio Ventures, a Chairman & Manager at Hangzhou Bota Biosciences Co., Ltd.
and a Chief Executive Officer at Bota Biosciences, Inc. She is on the Board of Directors at HiFiBiO Inc. and Rootpath Genomics, Inc.
Dr. Cui was previously employed as a Co-founder by Rootpath Genomics, Inc.
She received her graduate degree from the University of Toronto and a doctorate degree from Massachusetts Institute of Technology.
Cheryl Cui active positions
Companies | Position | Start |
---|---|---|
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Founder | 31/12/2016 |
Bota Biosciences, Inc. | Chief Executive Officer | - |
Hangzhou Bota Biosciences Co., Ltd.
Hangzhou Bota Biosciences Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing. | Chairman | 23/09/2020 |
Rootpath Genomics, Inc.
Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | - |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Director/Board Member | - |
Former positions of Cheryl Cui
Companies | Position | End |
---|---|---|
Rootpath Genomics, Inc.
Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Founder | - |
Training of Cheryl Cui
Massachusetts Institute of Technology | Doctorate Degree |
University of Toronto | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Finance |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
Rootpath Genomics, Inc.
Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Hangzhou Bota Biosciences Co., Ltd.
Hangzhou Bota Biosciences Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing. | Commercial Services |
Bota Biosciences, Inc. |
- Stock Market
- Insiders
- Cheryl Cui